Suppr超能文献

胆管癌术后调强放疗与三维适形放疗的回顾性分析

Retrospective analysis of intensity-modulated radiotherapy and three-dimensional conformal radiotherapy of postoperative treatment for biliary tract cancer.

作者信息

Lee Hyo Chun, Lee Jong Hoon, Lee Sea-Won, Lee Joo Hwan, Yu Mina, Jang Hong Seok, Kim Sung Hwan

机构信息

Department of Radiation Oncology, St. Vincent's Hospital, College of Medicine, The Catholic University of Korea, Suwon, Korea.

Department of Radiation Oncology, Seoul St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea.

出版信息

Radiat Oncol J. 2019 Dec;37(4):279-285. doi: 10.3857/roj.2019.00430. Epub 2019 Dec 31.

Abstract

PURPOSE

This study was conducted to compare the outcome of three-dimensional conformal radiotherapy (3D-CRT) and intensity-modulated radiotherapy (IMRT) for the postoperative treatment of biliary tract cancer.

MATERIALS AND METHODS

From February 2008 to June 2016, 57 patients of biliary tract cancer treated with curative surgery followed by postoperative 3D-CRT (n = 27) or IMRT (n = 30) were retrospectively enrolled.

RESULTS

Median follow-up time was 23.6 months (range, 5.2 to 97.6 months) for all patients and 38.4 months (range, 27.0 to 89.2 months) for survivors. Two-year recurrence-free survival is higher in IMRT arm than 3D-CRT arm with a marginal significance (25.9% vs. 47.4%; p = 0.088). Locoregional recurrence-free survival (64.3% vs. 81.7%; p = 0.122) and distant metastasis-free survival (40.3% vs. 55.8%; p = 0.234) at two years did not show any statistical difference between two radiation modalities. In the multivariate analysis, extrahepatic cholangiocarcinoma, poorly-differentiated histologic grade, and higher stage were significant poor prognostic factors for survival. Severe treatment-related toxicity was not significantly different between two arms.

CONCLUSION

IMRT showed comparable results with 3D-CRT in terms of recurrence, and survival, and radiotherapy toxicity for the postoperative treatment of biliary tract cancer.

摘要

目的

本研究旨在比较三维适形放疗(3D-CRT)和调强放疗(IMRT)在胆管癌术后治疗中的疗效。

材料与方法

回顾性纳入2008年2月至2016年6月期间57例接受根治性手术且术后接受3D-CRT(n = 27)或IMRT(n = 30)治疗的胆管癌患者。

结果

所有患者的中位随访时间为23.6个月(范围5.2至97.6个月),存活患者为38.4个月(范围27.0至89.2个月)。IMRT组的两年无复发生存率高于3D-CRT组,差异具有边缘显著性(25.9%对47.4%;p = 0.088)。两种放疗方式在两年时的局部区域无复发生存率(64.3%对81.7%;p = 0.122)和远处转移无复发生存率(40.3%对55.8%;p = 0.234)均无统计学差异。多因素分析显示,肝外胆管癌、低分化组织学分级和更高分期是生存的显著不良预后因素。两组之间严重的治疗相关毒性无显著差异。

结论

在胆管癌术后治疗的复发、生存及放疗毒性方面,IMRT与3D-CRT结果相当。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/22de/6952718/9ebb353449fd/roj-2019-00430f1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验